🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Emerson shares target raised by Oppenheimer on strong performance

EditorEmilio Ghigini
Published 05/10/2024, 05:27 AM
EMR
-

On Friday, Oppenheimer adjusted its outlook on Emerson (NYSE:EMR) shares, increasing the price target to $125 from $120 while maintaining an Outperform rating.

This adjustment comes as Emerson reported an 8% organic growth compared to the guided range of 3.5-5.5% and a 14% growth in the second fiscal quarter of 2023. The Measurement and Analytical segment was highlighted for its significant contribution to this performance, attributed to faster backlog execution.

Emerson's recent financial beat was widespread, with six out of seven subsegments surpassing expectations in both operating profit and operating margin. The Safety & Productivity segment performed approximately in line with forecasts.

Despite a 1% year-over-year decline in orders, which aligned with previous guidance and reflected a challenging comparison, Emerson is still on track to achieve a mid-single-digit year-over-year orders growth in the second half of the fiscal year and a low-to-mid single-digit growth for fiscal year 2024.

The company's project funnel has seen an increase of $0.4 billion sequentially, reaching a robust $10.8 billion. This growth is partly due to mergers and acquisitions, which are expected to contribute to Emerson's typical higher second-half versus first-half fiscal year sales seasonality.

This projection excludes contributions from AspenTech and T&M/National Instruments, both of which have already delivered revenue and margin upside in the second fiscal quarter.

Emerson's performance in the process and hybrid markets has been consistent, maintaining a mid-single-digit trend. The company's success in these markets is expected to continue, contributing to the overall positive outlook for the upcoming fiscal periods.

InvestingPro Insights

Emerson (NYSE:EMR) has demonstrated a strong financial performance with its recent earnings beat, and Oppenheimer's increased price target reflects optimism in the company's growth trajectory. To complement this perspective, InvestingPro data offers additional insights. Emerson boasts an impressive market capitalization of $66.08 billion, underlining its significant presence in the industry. The company's P/E ratio stands at 33.44, indicating investors' willingness to pay a premium for its earnings, potentially due to its consistent dividend increases for 53 consecutive years, as highlighted by one of the InvestingPro Tips. Additionally, Emerson's gross profit margin for the last twelve months as of Q2 2024 is a robust 49.65%, which underscores its efficiency and ability to maintain profitability.

Investors seeking stability might find Emerson's low price volatility appealing, another point raised in the InvestingPro Tips. Furthermore, the company's significant return over the last week of 8.49% showcases its recent market performance. For those interested in deeper analysis and more tips, InvestingPro provides 17 additional tips for Emerson. To access these insights and enhance your investment strategy, consider using the promo code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.